Literature DB >> 31879563

Liver Transplantation Using Steatotic Grafts.

Kyle R Jackson1, Jane Long1, Benjamin Philosophe1, Jacqueline Garonzik-Wang1.   

Abstract

Year:  2019        PMID： 31879563      PMCID： PMC6924967          DOI： 10.1002/cld.847

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  11 in total

1.  Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm.

Authors:  Kenneth D Chavin; David J Taber; Melissa Norcross; Nicole A Pilch; Heather Crego; John W McGillicuddy; Charles F Bratton; Angello Lin; Prabhakar K Baliga
Journal:  Clin Transplant       Date:  2013-09-02       Impact factor: 2.863

2.  Hepatic steatosis is not always a contraindication for cadaveric liver transplantation.

Authors:  Jan P Deroose; Geert Kazemier; Pieter Zondervan; Jan N M Ijzermans; Herold J Metselaar; Ian P J Alwayn
Journal:  HPB (Oxford)       Date:  2011-04-07       Impact factor: 3.647

3.  The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.

Authors:  Austin L Spitzer; Oliver B Lao; André A S Dick; Ramasamy Bakthavatsalam; Jeffrey B Halldorson; Matthew M Yeh; Melissa P Upton; Jorge D Reyes; James D Perkins
Journal:  Liver Transpl       Date:  2010-07       Impact factor: 5.799

4.  A randomized trial of normothermic preservation in liver transplantation.

Authors:  David Nasralla; Constantin C Coussios; Hynek Mergental; M Zeeshan Akhtar; Andrew J Butler; Carlo D L Ceresa; Virginia Chiocchia; Susan J Dutton; Juan Carlos García-Valdecasas; Nigel Heaton; Charles Imber; Wayel Jassem; Ina Jochmans; John Karani; Simon R Knight; Peri Kocabayoglu; Massimo Malagò; Darius Mirza; Peter J Morris; Arvind Pallan; Andreas Paul; Mihai Pavel; M Thamara P R Perera; Jacques Pirenne; Reena Ravikumar; Leslie Russell; Sara Upponi; Chris J E Watson; Annemarie Weissenbacher; Rutger J Ploeg; Peter J Friend
Journal:  Nature       Date:  2018-04-18       Impact factor: 49.962

Review 5.  Liver transplantation using fatty livers: always feasible?

Authors:  Lucas McCormack; Philipp Dutkowski; Ashraf Mohammad El-Badry; Pierre-Alain Clavien
Journal:  J Hepatol       Date:  2010-11-13       Impact factor: 25.083

6.  Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.

Authors:  Esther L de Graaf; James Kench; Pamela Dilworth; Nicholas A Shackel; Simone I Strasser; David Joseph; Henry Pleass; Michael Crawford; Geoff W McCaughan; Deborah J Verran
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

7.  The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score.

Authors:  Philipp Dutkowski; Andrea Schlegel; Ksenija Slankamenac; Christian E Oberkofler; Rene Adam; Andrew K Burroughs; Eric Schadde; Beat Müllhaupt; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2012-11       Impact factor: 12.969

Review 8.  Pathology of fatty liver disease.

Authors:  Elizabeth M Brunt
Journal:  Mod Pathol       Date:  2007-02       Impact factor: 7.842

9.  Use of severely steatotic grafts in liver transplantation: a matched case-control study.

Authors:  Lucas McCormack; Henrik Petrowsky; Wolfram Jochum; Beat Mullhaupt; Markus Weber; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

10.  Manipulation of Lipid Metabolism During Normothermic Machine Perfusion: Effect of Defatting Therapies on Donor Liver Functional Recovery.

Authors:  Yuri L Boteon; Joseph Attard; Amanda P C S Boteon; Lorraine Wallace; Gary Reynolds; Stefan Hubscher; Darius F Mirza; Hynek Mergental; Ricky H Bhogal; Simon C Afford
Journal:  Liver Transpl       Date:  2019-07       Impact factor: 5.799
View more
  3 in total

Review 1.  An Update on Usage of High-Risk Donors in Liver Transplantation.

Authors:  Haris Muhammad; Duha Zaffar; Aniqa Tehreem; Peng-Sheng Ting; Cem Simsek; Ilker Turan; Saleh Alqahtani; Behnam Saberi; Ahmet Gurakar
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

2.  Identification and Isolation of Type II NKT Cell Subsets in Human Blood and Liver.

Authors:  Jordi Yang Zhou; Jens M Werner; Gunther Glehr; Edward K Geissler; James A Hutchinson; Katharina Kronenberg
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

3.  A Clinical Tool to Guide Selection and Utilization of Marginal Donor Livers With Graft Steatosis in Liver Transplantation.

Authors:  Justin A Steggerda; Daniel Borja-Cacho; Todd V Brennan; Tsuyoshi Todo; Nicholas N Nissen; Matthew B Bloom; Andrew S Klein; Irene K Kim
Journal:  Transplant Direct       Date:  2022-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.